Request Demo
Last update 06 Mar 2025
Beijing Nuoweikang Medical Technology Co. Ltd.
Subsidiary Company|
2004|
Beijing Shi, China
Last update 06 Mar 2025
Overview
Related
CTR20222897
多中心、开放、多次给药评价注射用 STSP-0601 在不伴抑制物血友病患者中的安全性及初步有效性的 II 期临床研究
[Translation] A multicenter, open-label, multiple-dose Phase II clinical study to evaluate the safety and preliminary efficacy of STSP-0601 for injection in patients with hemophilia without inhibitors
CTR20150546
随机、双盲、安慰剂对照评价注射用凝血因子X激活剂单次给药在健康志愿者中的安全性和耐受性的Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase I clinical study to evaluate the safety and tolerability of a single dose of factor X activator for injection in healthy volunteers
100 Clinical Results associated with Beijing Nuoweikang Medical Technology Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Beijing Nuoweikang Medical Technology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Nuoweikang Medical Technology Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 16 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free